Loading viewer...
earnings
Format: PDF earnings
Ambu reports Q2 and H1 2024/25 results with 15.4% organic revenue growth and 15.2% EBIT margin expansion. The company achieved a strong start for its Ambu® SureLight™ Connect launch in pulmonology and continued positive momentum in urology. Management confirms current FY 2024/25 financial guidance.
investor_presentation
13 Pages
earnings
29 Pages
HDFC Bank
Brookfield Renewable Partners 2023 Full Year Earnings Presentation
earningsearnings
30 Pages
Brookfield Renewable Partners
Vontier Corporation Q2 2023 Earnings Results
earningsearnings
30 Pages
Vontier Corporation
Bird Construction Q4 2022 Earnings Results
earningsearnings
23 Pages
Bird Construction